Created in 2013 (Japan), BALINDAL own 440 sister brands and 4958 competing brands. BALINDAL is owned by Takeda Pharmaceutical, listed on the stock exchange of Francfort The ISIN, the company's International Securities Identification Number, is JP3463000004. BALINDAL is part of the Drug Manufacturers activity sector.